Terms: = Lung cancer AND MITF, WS2A, ENSG00000187098, 4286 AND Treatment
17 results:
1. Transcription Factor mitf Inhibits the Transcription of CPT1B to Regulate Fatty Acid β-Oxidation and Thus Affects Stemness in lung Adenocarcinoma Cells.
Tang W; Tang H; Xu S; Yu H; Chen Z
Pharmacology; 2024; 109(1):52-64. PubMed ID: 38016436
[TBL] [Abstract] [Full Text] [Related]
2. Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
Natsume T; Yoshida H; Nishikawa T; Kikkawa N; Naka T; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2023 Aug; 31(5):778-784. PubMed ID: 36310451
[TBL] [Abstract] [Full Text] [Related]
3. CD44+ and CD133+ Non-Small Cell lung cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant cancer Cell Enrichment Relating to Their p53 Status.
Pustovalova M; Blokhina T; Alhaddad L; Chigasova A; Chuprov-Netochin R; Veviorskiy A; Filkov G; Osipov AN; Leonov S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563313
[TBL] [Abstract] [Full Text] [Related]
4. HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin.
Biondini M; Kiepas A; El-Houjeiri L; Annis MG; Hsu BE; Fortier AM; Morin G; Martina JA; Sirois I; Aguilar-Mahecha A; Gruosso T; McGuirk S; Rose AAN; Tokat UM; Johnson RM; Sahin O; Bareke E; St-Pierre J; Park M; Basik M; Majewski J; Puertollano R; Pause A; Huang S; Keler T; Siegel PM
Oncogene; 2022 Mar; 41(12):1701-1717. PubMed ID: 35110681
[TBL] [Abstract] [Full Text] [Related]
5. RAD6B Loss Disrupts Expression of Melanoma Phenotype in Part by Inhibiting WNT/β-Catenin Signaling.
Sarma A; Gajan A; Kim S; Gurdziel K; Mao G; Nangia-Makker P; Shekhar MPV
Am J Pathol; 2021 Feb; 191(2):368-384. PubMed ID: 33181138
[TBL] [Abstract] [Full Text] [Related]
6. Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.
Ruiz J; Miller AA; Tooze JA; Crane S; Petty WJ; Gajra A; Klepin HD
J Geriatr Oncol; 2019 Jan; 10(1):48-54. PubMed ID: 30005982
[TBL] [Abstract] [Full Text] [Related]
7. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
8. cancer drug addiction is relayed by an ERK2-dependent phenotype switch.
Kong X; Kuilman T; Shahrabi A; Boshuizen J; Kemper K; Song JY; Niessen HWM; Rozeman EA; Geukes Foppen MH; Blank CU; Peeper DS
Nature; 2017 Oct; 550(7675):270-274. PubMed ID: 28976960
[TBL] [Abstract] [Full Text] [Related]
9. Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.
El-Awady RA; Hersi F; Al-Tunaiji H; Saleh EM; Abdel-Wahab AH; Al Homssi A; Suhail M; El-Serafi A; Al-Tel T
Cancer Biol Ther; 2015; 16(7):1056-70. PubMed ID: 25962089
[TBL] [Abstract] [Full Text] [Related]
10. Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama lung cancer Study Group Trial 1001.
Ichihara E; Hotta K; Nogami N; Kuyama S; Kishino D; Fujii M; Kozuki T; Tabata M; Harada D; Chikamori K; Aoe K; Ueoka H; Hosokawa S; Bessho A; Hisamoto-Sato A; Kubo T; Oze I; Takigawa N; Tanimoto M; Kiura K
J Thorac Oncol; 2015 Mar; 10(3):486-91. PubMed ID: 25695221
[TBL] [Abstract] [Full Text] [Related]
11. Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis.
Umemura S; Mimaki S; Makinoshima H; Tada S; Ishii G; Ohmatsu H; Niho S; Yoh K; Matsumoto S; Takahashi A; Morise M; Nakamura Y; Ochiai A; Nagai K; Iwakawa R; Kohno T; Yokota J; Ohe Y; Esumi H; Tsuchihara K; Goto K
J Thorac Oncol; 2014 Sep; 9(9):1324-31. PubMed ID: 25122428
[TBL] [Abstract] [Full Text] [Related]
12. Novel roles for the mitf/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis.
Martina JA; Diab HI; Li H; Puertollano R
Cell Mol Life Sci; 2014 Jul; 71(13):2483-97. PubMed ID: 24477476
[TBL] [Abstract] [Full Text] [Related]
13. Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway.
Bizzozero L; Cazzato D; Cervia D; Assi E; Simbari F; Pagni F; De Palma C; Monno A; Verdelli C; Querini PR; Russo V; Clementi E; Perrotta C
Cell Death Differ; 2014 Apr; 21(4):507-20. PubMed ID: 24317198
[TBL] [Abstract] [Full Text] [Related]
14. Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers.
Lin DC; Xu L; Ding LW; Sharma A; Liu LZ; Yang H; Tan P; Vadgama J; Karlan BY; Lester J; Urban N; Schummer M; Doan N; Said JW; Sun H; Walsh M; Thomas CJ; Patel P; Yin D; Chan D; Koeffler HP
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6109-14. PubMed ID: 23536305
[TBL] [Abstract] [Full Text] [Related]
15. Epidermal growth factor receptor tyrosine kinase inhibitors beyond progressive disease: a retrospective analysis for Japanese patients with activating EGFR mutations.
Nishie K; Kawaguchi T; Tamiya A; Mimori T; Takeuchi N; Matsuda Y; Omachi N; Asami K; Okishio K; Atagi S; Okuma T; Kubo A; Maruyama Y; Kudoh S; Takada M
J Thorac Oncol; 2012 Nov; 7(11):1722-7. PubMed ID: 23059777
[TBL] [Abstract] [Full Text] [Related]
16. Single agent maintenance therapy for advanced stage non-small cell lung cancer: a meta-analysis.
Behera M; Owonikoko TK; Chen Z; Kono SA; Khuri FR; Belani CP; Ramalingam SS
Lung Cancer; 2012 Aug; 77(2):331-8. PubMed ID: 22546678
[TBL] [Abstract] [Full Text] [Related]
17. Stage migration: results of lymph node dissection in the era of modern imaging and invasive staging for lung cancer.
Kirmani BH; Rintoul RC; Win T; Magee C; Magee L; Choong C; Wells FC; Coonar AS
Eur J Cardiothorac Surg; 2013 Jan; 43(1):104-9; discussion 109-10. PubMed ID: 22529185
[TBL] [Abstract] [Full Text] [Related]
